Cargando…
Detection of Antibodies against the Acetylcholine Receptor in Patients with Myasthenia Gravis: A Comparison of Two Enzyme Immunoassays and a Fixed Cell-Based Assay
The detection of serum anti-acetylcholine receptor (AChR) antibodies is currently an important tool for diagnosing myasthenia gravis (MG) since they are present in about 85% of MG patients. Many serological tests are now available. Nevertheless, results from these tests can be different in some pati...
Autores principales: | Gambino, Caterina Maria, Agnello, Luisa, Ciaccio, Anna Maria, Scazzone, Concetta, Vidali, Matteo, Di Stefano, Vincenzo, Milano, Salvatore, Brighina, Filippo, Candore, Giuseppina, Lo Sasso, Bruna, Ciaccio, Marcello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381261/ https://www.ncbi.nlm.nih.gov/pubmed/37510896 http://dx.doi.org/10.3390/jcm12144781 |
Ejemplares similares
-
Comparative Analysis of BIOCHIP Mosaic-Based Indirect Immunofluorescence with Enzyme-Linked Immunosorbent Assay for Diagnosing Myasthenia Gravis
por: Gambino, Caterina Maria, et al.
Publicado: (2021) -
FOXP3 and GATA3 Polymorphisms, Vitamin D3 and Multiple Sclerosis
por: Scazzone, Concetta, et al.
Publicado: (2021) -
Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine
por: Lo Sasso, Bruna, et al.
Publicado: (2021) -
Evaluation of the analytical performance of three chemiluminescence serological assays for detecting anti-SARS-CoV-2 antibodies
por: Lo Sasso, Bruna, et al.
Publicado: (2022) -
Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer’s Disease
por: Agnello, Luisa, et al.
Publicado: (2021)